NEWS

Posted on :

December 15, 2024

Kolosis Announces the Appointment of Val Begley as Director of Cardiac Surgery

Kolosis BIO announced today the appointment of Val Begley as Director of Cardiac Surgery. Val brings extensive experience in surgical and biologics sales, particularly in spine and plastic and reconstructive surgery.

Before joining Kolosis, Valerie served as a Senior Surgical Consultant in the Plastics & Reconstruction division at MTF Biologics, where she supported physicians with advanced tissue technologies. Prior to that, she was a Physician Liaison at Nobilis Healthcare, managing relationships with surgical specialists and driving procedural growth for over seven years. Valerie also held sales leadership roles with Biomet, Nuvasive, and Lanx, focusing on spine and orthobiologics technologies. While in each of these roles, Valerie distinguished herself as a highly customer-focused and exceptional team player. Her collaborative spirit earned her multiple awards as voted by her internal colleagues.

Valerie earned her degree from Oklahoma State University.

About Kolosis BIO:

Kolosis BIO is a leading provider of innovative biologic solutions, dedicated to commercializing cutting-edge technologies and delivering market-leading products to the orthopedic industry. As a pure-play biologics company, Kolosis BIO exclusively partners with MTF Biologics to offer superior quality bone graft technologies such as Kore Fiber, a 100% cortical fiber allograft and Prime HD, a pre-hydrated DBM. These allografts are backed by MTF’s proprietary aseptic processing methods that optimally preserve matrix structures and osteoinductive properties.

As the company looks to the future, Kolosis is dedicated to driving innovation in the biologics field, expanding its product offerings and pushing the boundaries of science to enhance patient outcomes. With a focus on relentless execution and bold technologies, Kolosis BIO endeavors to become a leading force in the biologics market. For more information, please visit www.kolosis.com.

About MTF Biologics:

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. They provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.

The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation), expands its reach to patients across the globe. For more information, visit www.mtfbiologics.org.